6 HR.QUALITY ASSIGN.2

The fight for Pre-Exposure Prophylaxis in the United Kingdom.

Collapse

Top of Form

Total views: 2 (Your views: 1)

The Client: The National AIDS Trust (NAT) is the United Kingdom's leading charity dedicated to transforming society's response to HIV (NAT, 2016). Founded in 1987, NAT has spent over 20 years promoting public health through effective HIV prevention and early diagnosis of HIV infection, especially when it comes to pre-exposure prophylaxis. 

Problem Statement: What can be done to combat the recent decision by the National Health Service (NHS) in England to abandon its work to provide PrEP?

Stakeholders:

The National Health Service in England: Sets the priorities and direction of the NHS and encourages/informs the national debate to improve health and care (NHS, 2016). NHS England recently decided to discontinue 18 months of work which demonstrated the need, efficacy, and cost-effectiveness of PrEP.

Individuals at risk for HIV: The number and rate of new diagnoses of HIV is continuing to rise in eastern Europe, and is also rising sharply in central Europe (NAM, 2015)

Healthcare providers: As the incidence rates of HIV continue to increase, health care providers are going to find it increasingly more difficult to help these individuals without new treatments.

Public Health England: Has funded research to prove the efficacy of PrEP.

Taxpayers: Many fear funding of further research into PrEP will come out of their own pockets.

Gilead Sciences, Inc.: The pharmaceutical company responsible for developing Truvada, a known PrEP drug.

Journal:

The Journal of the International AIDS Society (JIAS) was founded in 2004 by the International AIDS Society as a platform to disseminate essential HIV research with the mission to contribute to evidence-based response to the HIV epidemic and to support research capacity building in resource-limited settings (JIAS, 2016). 

JIAS has the following requirements for submitting commentary articles (focused and opinionated articles on important and timely issues). All information has been taking from the JIAS Author Guidelines resource page:

Headings: Introduction, Discussion, Conclusions.

Work Limit: 2500 words.

Abstract Limit: 350 words.

Numbers of figures and tables: 1.

Additional Files: No.

Citation Style: All external sources of information should be referenced within the text, tables and figures, and using consecutive numbering in square brackets, e.g. [1], [3-5], [3,4]. Numbers of references are unlimited and should be formatted in standard Vancouver style. Unpublished observations, personal communications, and manuscripts currently under consideration should be cited in the test in round brackets and not in the reference list.

Link to Sample References: http://www.nlm.nih.gov/bsd/uniform_requirements.html

Link to Author's Guide: http://www.jiasociety.org/index.php/jias/about/submissions#onlineSubmissions

Reference:

"About NHS England." NHS England. N.p., 2016. Web. 12 June 2016. <http://www.england.nhs.uk/about/>

"Journal History." Journal of the International AIDS Society. The International AIDS Society. 2016. Web. 12 June 2016. <http://www.jiasociety.org/index.php/jias/about/history>.

"Who We Are." NAT. National AIDS Trust Corp., 2016. Web. 12 June 2016. <http://www.nat.org.uk/About-us/Who-we-are.aspx>.

"UK Maintains the Largest HIV Epidemic in Western Europe." HIV & AIDS Information. NAM Publications, 15 Dec. 2015. Web. 12 June 2016. <http://www.aidsmap.com/UK-maintains-the-largest-HIV-epidemic-in-western-Europe/page/3021724/>. 

Bottom of Form

d3055fba-65b8-4

false